Paloma Partners’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
FAM
DGI
CPH
Paloma Partners's CLB Position: Q1 2022 in Review
Paloma Partners sold out of Core Laboratories (CLB) in Q1 2022, closing a stake of 16,726 shares — an estimated $373K sold.
Paloma Partners first reported a position in CLB in Q4 2013 and held it in 16 quarters. The position peaked at $5.74M in Q4 2017. 196 funds tracked by Wall St. Rank hold CLB as of Q1 2022.
- Paloma Partners reported no remaining Core Laboratories position as of Q1 2022 after selling out during the quarter.
- Paloma Partners sold 16,726 Core Laboratories shares in Q1 2022, an estimated $373K.
- Paloma Partners first reported a position in Core Laboratories in Q4 2013 and held it in 16 quarters.
- Paloma Partners's Core Laboratories position peaked at $5.74M in Q4 2017.
- 196 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2022.
Based on Paloma Partners's 13F filing for Q1 2022, filed 16 May 2022.